Can a cholesterol drug tame sepsis? new trial aims to find out
NCT ID NCT07572552
First seen May 08, 2026 · Last updated May 21, 2026 · Updated 3 times
Summary
This study compares two drugs—fenofibrate (a cholesterol medicine) and silymarin (a milk thistle extract)—in 66 adults with sepsis, a life-threatening infection that can cause organ failure. The goal is to see which drug better reduces inflammation and organ damage. Participants must be 18 or older and diagnosed with sepsis; those with severe organ failure or certain pre-existing conditions cannot join.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.